KN
Kinnate Bio
KNTE·NASDAQSan Diego CAFounded 201740 employees
Micro CapbiotechPublicOncology
Platform: RAF/MEK Onc
Market Cap
$0.05B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (KNTE)
Loading KNTE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tiralucimab | KNT-4922 | Phase 2 | 1 | TNFα | MesoNarcolepsy | ||
| Olpafotisoran | KNT-4823 | Phase 2 | 1 | IL-13 | UCT2D |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)